Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5,561Revenue $M2,335Net Margin (%)10.3Z-Score8.1
Enterprise Value $M5,815EPS $18.4Operating Margin %16.1F-Score6
P/E(ttm))23.8Cash Flow Per Share $17.7Pre-tax Margin (%)15.1Higher ROA y-yN
Price/Book12.710-y EBITDA Growth Rate %22.8Quick Ratio1.8Cash flow > EarningsY
Price/Sales2.55-y EBITDA Growth Rate %11.3Current Ratio3.2Lower Leverage y-yN
Price/Cash Flow15.6y-y EBITDA Growth Rate %8.4ROA % (ttm)18.9Higher Current Ratio y-yN
Dividend Yield %1.1Insider Buy (3m)0ROE % (ttm)49.8Less Shares Outstanding y-yY
Payout Ratio %26.0Shares Outstanding M12.4ROI % (ttm)29.5Gross Margin Increase y-yY

Gurus Latest Trades with NEU

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NEUMario Gabelli 2015-03-31 Reduce-0.01%$395.42 - $480.33
($451.21)
$ 453.420%Reduce -9.93%27,200
NEUJoel Greenblatt 2014-12-31 Buy $354.08 - $410.17
($386.15)
$ 453.4215%New holding615
NEUJoel Greenblatt 2014-09-30 Sold Out -0.05%$383.07 - $413.39
($396.95)
$ 453.4212%Sold Out0
NEUJoel Greenblatt 2014-03-31 Reduce-0.03%$311.61 - $392.52
($353.34)
$ 453.4222%Reduce -25.05%10,039
NEUJoel Greenblatt 2013-12-31 Reduce-0.05%$283.29 - $337.22
($314.78)
$ 453.4231%Reduce -28.09%13,395
NEUJoel Greenblatt 2013-09-30 Add0.09%$264.88 - $291.85
($277.64)
$ 453.4239%Add 110.05%18,627
NEUPrem Watsa 2013-09-30 Buy 0.01%$264.88 - $291.85
($277.64)
$ 453.4239%New holding750
NEUJoel Greenblatt 2013-06-30 Reduce-0.06%$256.88 - $280.37
($270.11)
$ 453.4240%Reduce -34.96%8,868
NEUJoel Greenblatt 2013-03-31 Add0.11%$241.65 - $288.16
($262.24)
$ 453.4242%Add 169.41%13,635
NEUIrving Kahn 2012-12-31 Reduce-0.02%$233.15 - $277.43
($255.13)
$ 453.4244%Reduce -28.30%1,140
NEUPrem Watsa 2012-12-31 Sold Out -0.01%$233.15 - $277.43
($255.13)
$ 453.4244%Sold Out0
NEUIrving Kahn 2012-06-30 Reduce-0.03%$183.05 - $228.58
($205.03)
$ 453.4255%Reduce -37.52%1,665
NEUJoel Greenblatt 2012-06-30 Add0.02%$183.05 - $228.58
($205.03)
$ 453.4255%Add 25.12%6,959
NEUPrem Watsa 2012-06-30 Reduce-0.01%$183.05 - $228.58
($205.03)
$ 453.4255%Reduce -50.00%1,000
NEUJoel Greenblatt 2012-03-31 Add0.07%$173.46 - $220.29
($182.46)
$ 453.4260%Add 273.79%5,562
NEUIrving Kahn 2011-09-30 Reduce-0.04%$135.01 - $178.16
($162.25)
$ 453.4264%Reduce -31.48%3,265
NEUJoel Greenblatt 2011-09-30 Buy 0.03%$135.01 - $178.16
($162.25)
$ 453.4264%New holding1,410
NEUPrem Watsa 2011-09-30 Reduce-0.01%$135.01 - $178.16
($162.25)
$ 453.4264%Reduce -37.50%2,500
NEUJoel Greenblatt 2011-06-30 Sold Out -0.25%$149.97 - $185.4
($166.75)
$ 453.4263%Sold Out0
NEUJoel Greenblatt 2011-03-31 Buy 0.25%$119.76 - $159.26
($133.12)
$ 453.4271%New holding5,217
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NEU is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


NEU: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GOTTWALD THOMAS EChairman, President & CEO 2015-02-25Sell10,000$471.11-2.04view
FIORENZA DAVID AVP & CFO 2015-02-03Sell294$452.092.09view
Shama Robert A.President Afton Chemical Corp 2014-11-06Sell601$386.119.53view
Hazelgrove Bruce R IIIVice President & CAO 2014-10-31Sell243$385.1919.82view
GOTTWALD THOMAS EChairman, President & CEO 2014-08-26Sell10,000$406.8313.44view
FIORENZA DAVID AVP & CFO 2014-02-21Sell700$367.2725.66view
FIORENZA DAVID AVP & CFO 2013-11-11Sell1,000$312.0947.88view
FIORENZA DAVID AVP & CFO 2013-05-01Sell1,000$263.2175.34view
HANLEY PATRICK DDirector 2013-01-30Buy200$256.1780.16view
GAMBILL MARK MDirector 2013-01-30Buy500$256.0780.23view

Press Releases about NEU :

Quarterly/Annual Reports about NEU:

News about NEU:

Articles On GuruFocus.com
Prem Watsa's Stocks With Growing EBITDA Apr 08 2015 
Prem Watsa Top Growing Stocks Feb 23 2015 
Neuren's NNZ-2566 Successful in Demonstrating Clinical Benefit in Rett Syndrome Phase 2 Trial Nov 12 2014 
NewMarket Corp: Fundamental Stock Research Analysis Feb 28 2013 
A Review of the 10 Best Performing Growth Stocks from the Past Decade Dec 29 2012 
IOSP vs NEU......which one will win on a percentage return basis in 10 years Dec 17 2012 
11 Dividend Challengers With Highest Dividend Payout Potential Aug 15 2012 
Enhance the Performance of Your Portfolio with NewMarket Corp. Apr 24 2012 
24 Stocks Providing an Inflation Hedge with Increasing Dividends Oct 31 2011 
Guru Stocks Raising Dividends: NEU, MAC, WMK, KMT, VLO Oct 31 2011 

More From Other Websites
NewMarket Corporation Declares Quarterly Dividend Apr 24 2015
NEWMARKET CORP Files SEC form 8-K, Results of Operations and Financial Condition, Other Events,... Apr 23 2015
NewMarket Corporation Declares Quarterly Dividend Apr 23 2015
NewMarket Corporation Reports First Quarter 2015 Results Apr 23 2015
NewMarket posts 1Q profit Apr 22 2015
NewMarket posts 1Q profit Apr 22 2015
5:02 pm NewMarket beats by $0.39, beats on revs Apr 22 2015
NewMarket Corporation Reports First Quarter 2015 Results Apr 22 2015
NewMarket Corporation to Host First Quarter 2015 Earnings Conference Call and Webcast Live on... Apr 22 2015
Q1 2015 NewMarket Corp Earnings Release - After Market Close Apr 22 2015
NEUCA SHARES REDEMPTION FAVOURABLE FOR INVESTORS Apr 15 2015
NEUCA AMONG THE FORERUNNERS OF THE DEVELOPING MARKET Apr 15 2015
NEUCA – AN INVESTMENT TARGET FOR 2015 Apr 14 2015
NEUCA AMONG DIVIDEND ATTRACTIVE COMPANIES Apr 14 2015
NEUCA TOPS IN CONTEST „STOCK-LISTED COMPANY OF THE YEAR” IN CATEGORY: DEVELOPMENT PERSPECTIVES Apr 14 2015
STOCKWATCH: NEUCA AMONG THE MOST ATTRACTIVE DIVIDEND COMPANIES Apr 14 2015
NEUCA TO INVEST PLN 50 MILLION Apr 14 2015
AMBITIOUS FORECAST FOR NEUCA Apr 14 2015
NEUCA ESTIMATES PLN 100 MILLION PROFIT IN 2015 Apr 14 2015
NEUCA INVESTS IN THE COMPANIES FROM CLINICAL TRIALS AND TELEMEDICINE INDUSTRIES Apr 14 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK